Global Navigation

Sub Men


Not currently logged in
Email:
Password:

Shire launches ADHD drug

Pharmaceutical company, Shire, has launched Vyvanse in the US for the treatment of adults with attention deficit hyperactivity disorder
Pharmaceutical company, Shire, has launched Vyvanse in the US for the treatment of adults with attention deficit hyperactivity disorder (ADHD) and has called on American celebrity designer, Ty Pennington, to help raise awareness of the condition.

Pennington, host of ABC's Extreme Makeover: Home Edition television programme, is himself a sufferer of ADHD. As part of the awareness campaign, Pennington helped launch an ADHD Scholarship for an adult with the condition who intends to pursue education or training for a creative career. Shire is sponsoring the scholarship, which will be worth $10,000 and be available for graduates of the Savannah College of Art and Design in Atlanta.

"As an adult with ADHD, I know, firsthand, the importance of understanding and treating ADHD," said Pennington. "Today, I have a very demanding schedule with long production days and constant travel, and I take Vyvannse to help control my ADHD symptoms so that I can focus and organise."

The US Food and Drug Administration approved Vyvannse for use in April 2008 for the treatment of adults with ADHD between 18 and 55 years old. The drug was first introduced on the market for use in children with ADHD between the ages of 6 and 12. It is now available in pharmacies across the US on prescription from a healthcare professional.

23rd July 2008

Share